Tuesday, 24 July 2018

AbbVie prices new endometriosis drug at $10,000 a year

Drugmaker AbbVie Inc priced its new endometriosis drug Orilissa at around $10,000 a year after receiving approval from U.S. regulators for the treatment on Tuesday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)